C/EBPα redirects androgen receptor signaling through a unique bimodal interaction (original) (raw)

• Aarnisalo P, Palvimo JJ, Jänne OA . (1998). CREB-binding protein in androgen receptor-mediated signaling. Proc Natl Acad Sci 95: 2122–2127.
  Article CAS PubMed PubMed Central Google Scholar
• Baron S, Manin M, Beaudoin C, Leotoing L, Communal Y, Veyssiere G et al. (2004). Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J Biol Chem 279: 14579–14586.
  Article CAS PubMed Google Scholar
• Beato M, Herrlich P, Schutz G . (1995). Steroid hormone receptors: many actors in search of a plot. Cell 83: 851–857.
  Article CAS PubMed Google Scholar
• Berrevoets CA, Doesburg P, Steketee K, Trapman J, Brinkmann AO . (1998). Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). Mol Endocrinol 12: 1172–1183.
  Article CAS PubMed Google Scholar
• Bourguet W, Germain P, Gronemeyer H . (2000). Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol Sci 21: 381–388.
  Article CAS PubMed Google Scholar
• Burel SA, Harakawa N, Zhou L, Pabst T, Tenen DG, Zhang DE . (2001). Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation. Mol Cell Biol 21: 5577–5590.
  Article CAS PubMed PubMed Central Google Scholar
• Chattopadhyay S, Gong EY, Hwang M, Park E, Lee HJ, Hong CY et al. (2006). The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells. Mol Endocrinol 20: 984–995.
  Article CAS PubMed Google Scholar
• Edwards J, Bartlett JM . (2005). The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: modifications to the androgen receptor. BJU Int 95: 1320–1326.
  Article CAS PubMed Google Scholar
• Ettwiller L, Paten B, Ramialison M, Birney E, Wittbrodt J . (2007). Trawler: de novo regulatory motif discovery pipeline for chromatin immunoprecipitation. Nat Methods 4: 563–565.
  Article CAS PubMed Google Scholar
• Frønsdal K, Engedal N, Slagsvold T, Saatcioglu F . (1998). CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. J Biol Chem 273: 31853–31859.
  Article PubMed Google Scholar
• Gelmann EP . (2002). Molecular biology of the androgen receptor. J Clin Oncol 20: 3001–3015.
  Article CAS PubMed Google Scholar
• Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP . (2005). Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Clin Cancer Res 11: 3184–3190.
  Article CAS PubMed Google Scholar
• Glass CK, Rosenfeld MG . (2000). The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14: 121–141.
  CAS PubMed Google Scholar
• Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG . (2002). Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Cancer Res 62: 528–534.
  CAS PubMed Google Scholar
• Han S, Roman J . (2007). Peroxisome proliferator-activated receptor gamma: a novel target for cancer theraputics? Anticancer Drugs 18: 237–244.
  Article CAS PubMed Google Scholar
• Harris TE, Albrecht JH, Nakanishi M, Darlington GJ . (2001). CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding. J Biol Chem 276: 29200–29209.
  Article CAS PubMed Google Scholar
• Hendricks-Taylor LR, Darlington GJ . (1995). Inhibition of cell proliferation by C/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen. Nucleic Acids Res 23: 4726–4733.
  Article CAS PubMed PubMed Central Google Scholar
• Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR . (1996). GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 93: 4948–4952.
  Article CAS PubMed PubMed Central Google Scholar
• Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL . (2001). Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 276: 13615–13621.
  Article CAS PubMed Google Scholar
• Jenster G, Trapman J, Brinkmann AO . (1993). Nuclear import of the human androgen receptor. Biochem J 293 (Pt 3): 761–768.
  Article CAS PubMed PubMed Central Google Scholar
• Jenster G, van der Korput HA, Trapman J, Brinkmann AO . (1995). Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 270: 7341–7346.
  Article CAS PubMed Google Scholar
• Jia L, Coetzee GA . (2005). Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus. Cancer Res 65: 8003–8008.
  Article CAS PubMed Google Scholar
• Kousteni S, Bellido T, Plotkin LI, O’Brien CA, Bodenner DL, Han L et al. (2001). Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104: 719–730.
  CAS PubMed Google Scholar
• Loomis KD, Zhu S, Yoon K, Johnson PF, Smart RC . (2007). Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis. Cancer Res 67: 6768–6776.
  Article CAS PubMed PubMed Central Google Scholar
• Manolagas SC, Kousteni S . (2001). Perspective: nonreproductive sites of action of reproductive hormones. Endocrinology 142: 2200–2204.
  Article CAS PubMed Google Scholar
• McEwan IJ . (2004). Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain. Endocr Relat Cancer 11: 281–293.
  Article CAS PubMed Google Scholar
• McKenna NJ, O’Malley BW . (2002). Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465–474.
  Article CAS PubMed Google Scholar
• Miyamoto H, Messing EM, Chang C . (2004). Androgen deprivation therapy for prostate cancer: current status and future prospects. Prostate 61: 332–353.
  Article CAS PubMed Google Scholar
• Muller C, Calkhoven CF, Sha X, Leutz A . (2004). The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest. J Biol Chem 279: 7353–7358.
  Article PubMed Google Scholar
• Nerlov C, Ziff EB . (1994). Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-alpha on the serum albumin promoter. Genes Dev 8: 350–362.
  Article CAS PubMed Google Scholar
• Osada S, Yamamoto H, Nishihara T, Imagawa M . (1996). DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. J Biol Chem 271: 3891–3896.
  Article CAS PubMed Google Scholar
• Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G et al. (2001a). AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat Med 7: 444–451.
  Article CAS PubMed Google Scholar
• Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S et al. (2001b). Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 27: 263–270.
  Article CAS PubMed Google Scholar
• Paltoo D, Woodson K, Taylor P, Albanes D, Virtamo J, Tangerea J . (2003). Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study. Cancer Lett 191: 67–74.
  Article CAS PubMed Google Scholar
• Porse BT, Pedersen TA, Xu X, Lindberg B, Wewer UM, Friis-Hansen L et al. (2001). E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo. Cell 107: 247–258.
  Article CAS PubMed Google Scholar
• Pratt WB, Toft DO . (1997). Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18: 306–360.
  CAS PubMed Google Scholar
• Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS . (1995). Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16: 271–321.
  CAS PubMed Google Scholar
• Ramji DP, Foka P . (2002). CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561–575.
  Article CAS PubMed PubMed Central Google Scholar
• Roy AK, Lavrovsky Y, Song CS, Chen S, Jung MH, Velu NK et al. (1999). Regulation of androgen action. Vitam Horm 55: 309–352.
  Article CAS PubMed Google Scholar
• Ruizeveld de Winter JA, Janssen PJ, Sleddens HM, Verleun-Mooijman MC, Trapman J, Brinkmann AO et al. (1994). Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 144: 735–746.
  CAS PubMed PubMed Central Google Scholar
• Sadowski I, Ptashne M . (1989). A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res 17: 7539.
  Article CAS PubMed PubMed Central Google Scholar
• Safe S, Kim K . (2004). Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog Nucleic Acid Res Mol Biol 77: 1–36.
  Article CAS PubMed Google Scholar
• Schoenmakers E, Verrijdt G, Peeters B, Verhoeven G, Rombauts W, Claessens F . (2000). Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J Biol Chem 275: 12290–12297.
  Article CAS PubMed Google Scholar
• Schuster MB, Porse BT . (2006). C/EBPalpha: a tumour suppressor in multiple tissues? Biochim Biophys Acta 1766: 88–103.
  CAS PubMed Google Scholar
• Shaffer PL, Jivan A, Dollins DE, Claessens F, Gewirth DT . (2004). Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci USA 101: 4758–4763.
  Article CAS PubMed PubMed Central Google Scholar
• Shand RL, Gelmann EP . (2006). Molecular biology of prostate-cancer pathogenesis. Curr Opin Urol 16: 123–131.
  Article PubMed Google Scholar
• Shatnawi A, Tran T, Ratnam M . (2007). R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism. Mol Endocrinol 21: 635–650.
  Article CAS PubMed Google Scholar
• Sun M, Yang L, Feldman RI, Sun XM, Bhalla KN, Jove R et al. (2003). Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src. J Biol Chem 278: 42992–43000.
  Article CAS PubMed Google Scholar
• Sundfeldt K, Ivarsson K, Carlsson M, Enerback S, Janson PO, Brannstrom M et al. (1999). The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPbeta during epithelial tumour progression. Br J Cancer 79: 1240–1248.
  Article CAS PubMed PubMed Central Google Scholar
• Thomson AA, Marker PC . (2006). Branching morphogenesis in the prostate gland and seminal vesicles. Differentiation 74: 382–392.
  Article CAS PubMed Google Scholar
• Timchenko NA, Harris TE, Wilde M, Bilyeu TA, Burgess-Beusse BL, Finegold MJ et al. (1997). CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol Cell Biol 17: 7353–7361.
  Article CAS PubMed PubMed Central Google Scholar
• Timchenko NA, Wilde M, Darlington GJ . (1999a). C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice. Mol Cell Biol 19: 2936–2945.
  Article CAS PubMed PubMed Central Google Scholar
• Timchenko NA, Wilde M, Iakova P, Albrecht JH, Darlington GJ . (1999b). E2F/p107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L1 adipocytes. Nucleic Acids Res 27: 3621–3630.
  Article CAS PubMed PubMed Central Google Scholar
• Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ . (1996). CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 10: 804–815.
  Article CAS PubMed Google Scholar
• Tsai MJ, O’Malley BW . (1994). Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63: 451–486.
  Article CAS PubMed Google Scholar
• Umek RM, Friedman AD, McKnight SL . (1991). CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251: 288–292.
  Article CAS PubMed Google Scholar
• Vlahopoulos S, Zimmer WE, Jenster G, Belaguli NS, Balk SP, Brinkmann AO et al. (2005). Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic gene. J Biol Chem 280: 7786–7792.
  Article CAS PubMed Google Scholar
• Wang GL, Iakova P, Wilde M, Awad S, Timchenko NA . (2004). Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity. Genes Dev 18: 912–925.
  Article CAS PubMed PubMed Central Google Scholar
• Wang GL, Timchenko NA . (2005). Dephosphorylated C/EBPalpha accelerates cell proliferation through sequestering retinoblastoma protein. Mol Cell Biol 25: 1325–1338.
  Article CAS PubMed PubMed Central Google Scholar
• Wang H, Goode T, Iakova P, Albrecht JH, Timchenko NA . (2002). C/EBPalpha triggers proteasome-dependent degradation of cdk4 during growth arrest. EMBO J 21: 930–941.
  Article CAS PubMed PubMed Central Google Scholar
• Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ et al. (2001). C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell 8: 817–828.
  Article CAS PubMed Google Scholar
• Wang Q, Li W, Liu XS, Carroll JS, Janne OA, Keeton EK et al. (2007). A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell 27: 380–392.
  Article PubMed PubMed Central Google Scholar
• Watkins PJ, Condreay JP, Huber BE, Jacobs SJ, Adams DJ . (1996). Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. Cancer Res 56: 1063–1067.
  CAS PubMed Google Scholar
• Wettenhall JM, Simpson KM, Satterley K, Smyth GK . (2006). affylmGUI: a graphical user interface for linear modeling of single channel microarray data. Bioinformatics 22: 897–899.
  Article CAS PubMed Google Scholar
• Xu Y, Chen SY, Ross KN, Balk SP . (2006). Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res 66: 7783–7792.
  Article CAS PubMed Google Scholar
• Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L et al. (2004). Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22: 2790–2799.
  Article CAS PubMed Google Scholar
• Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ . (2002). Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 62: 1008–1013.
  CAS PubMed Google Scholar
• Zhang J, Wilkinson JE, Gonit M, Keck R, Selman S, Ratnam M . (2008). Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the prostate. Prostate 68: 1206–1214.
  Article PubMed PubMed Central Google Scholar